Basel
Switzerland
22
2026-02-26
The entities that hold a legal rights for patent applications filed by inventor Dumortier Thomas:
Thomas Dumortier from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#2 | 2025-08-21DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#3 | 2023-03-23DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#4 | 2022-11-17METHODS OF TREATING AUTOIMMUNE DISEASES USING INTERLEUKIN-17 (IL-17) ANTAGONISTS
#5 | 2022-05-12DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#6 | 2020-10-22DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#7 | 2020-07-16Dosage regimen of an S1P receptor modulator
#8 | 2019-03-28DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#9 | 2018-10-11DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#10 | 2018-09-20DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#11 | 2018-09-20Dosage regimen of an S1P receptor modulator
#12 | 2017-10-26DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#13 | 2017-07-06DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#14 | 2016-09-15DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#15 | 2016-09-08DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#16 | 2016-03-24DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#17 | 2014-07-03DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#18 | 2014-05-29DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#19 | 2014-03-06DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#20 | 2012-10-18DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#21 | 2011-10-20DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
#22 | 2010-06-24DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
678312 ⎘